ArticleAnnals of medicine2025
AI-driven prediction of severe respiratory sequelae in COVID-19 patients.
Article in Annals of medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn coronavirus disease 2019 (COVID-19) patients, respiratory sequelae are common complications that significantly impact health outcomes. Hence, early identification of patients at risk is essential for improving prognosis and care. MATERIALS AND
methodsWe enrolled 516 COVID-19 patients and applied K-means algorithms to cluster them into subtypes based on clinical characteristics and risk profiles. ResNet-50 was employed to analyze and extract features from chest X-rays, accurately identifying COVID-19-related lesions. The extracted imaging data were integrated with clinical data to develop a predictive model aimed at stratifying post-COVID-19 patients by risk and identifying those likely to develop severe respiratory sequelae.
resultsWe identified two distinct COVID-19 subtypes, one of which was associated with severe respiratory sequelae. The convolutional neural networks (CNNs) accurately detected COVID-19-related lesions on chest X-rays. The predictive model showed excellent subtype discriminative ability, achieving an area under the curve (AUC) of 0.949 and 0.958 in the training and validation cohorts, respectively.
conclusionsOur AI-driven predictive model demonstrates strong potential for the early identification of respiratory sequelae in COVID-19 patients. By applying the K-means algorithm to cluster patients based on clinical characteristics, in combination with feature extraction from chest X-rays using the ResNet-50 deep learning model, we accurately stratified patients by their risk of severe respiratory outcomes. However, to evaluate its performance in clinical settings, further validation using larger, independent datasets is essential to confirm the model's reliability and generalizability across diverse populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.